We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$14.7B
AUM Growth
-$6.7B
Cap. Flow
-$8.87B
Cap. Flow %
-60.4%
Top 10 Hldgs %
30.89%
Holding
537
New
135
Increased
77
Reduced
139
Closed
111

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 1.73%
3 Utilities 1.59%
4 Financials 1.34%
5 Industrials 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
251
Alaunos Therapeutics
TCRT
$4.84M
$3.6M 0.02%
38,137
LCTX icon
252
Lineage Cell Therapeutics
LCTX
$286M
$3.57M 0.02%
2,377,940
URGN icon
253
UroGen Pharma
URGN
$2.26B
$3.52M 0.02%
380,600
VMW
254
DELISTED
VMware, Inc
VMW
$3.49M 0.02%
27,951
-270
-1% -$32.4K
DVN icon
255
PUT
Devon Energy
DVN
$49.9B
$3.45M 0.02%
+68,200
New +$3.88M
OMGA
256
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$3.44M 0.02%
571,108
+138,408
+32% +$964K
ZVRA icon
257
Zevra Therapeutics
ZVRA
$682M
$3.14M 0.02%
571,200
PFE icon
258
Pfizer
PFE
$154B
$3.11M 0.02%
76,184
+11,542
+18% +$499K
DVN icon
259
Devon Energy
DVN
$49.9B
$3.08M 0.02%
+60,916
New +$3.47M
AAL icon
260
American Airlines Group
AAL
$9.93B
$3.01M 0.02%
+203,845
New +$3.18M
TRDA icon
261
Entrada Therapeutics
TRDA
$271M
$2.89M 0.02%
199,066
AUTL
262
Autolus Therapeutics
AUTL
$551M
$2.76M 0.02%
1,500,000
RAIN
263
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.74M 0.02%
313,200
UNP icon
264
Union Pacific
UNP
$174B
$2.65M 0.02%
13,165
-31,385
-70% -$6.36M
PANW icon
265
Palo Alto Networks
PANW
$314B
$2.6M 0.02%
+26,000
New +$2.2M
ON icon
266
PUT
ON Semiconductor
ON
$31.1B
$2.59M 0.02%
31,500
-50,400
-62% -$3.83M
KRE icon
267
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$2.54M 0.02%
57,900
+52,600
+992% +$2.98M
COST icon
268
Costco
COST
$423B
$2.53M 0.02%
5,092
-114,435
-96% -$56.1M
PNC icon
269
PUT
PNC Financial Services
PNC
$100B
$2.39M 0.02%
18,800
-246,500
-93% -$37.2M
MOH icon
270
Molina Healthcare
MOH
$10.4B
$2.14M 0.01%
+8,000
New +$2.3M
ARWR icon
271
Arrowhead Research
ARWR
$12.5B
$2.13M 0.01%
83,900
FIS icon
272
PUT
Fidelity National Information Services
FIS
$21.9B
$2.06M 0.01%
+37,900
New +$2.47M
UPS icon
273
CALL
United Parcel Service
UPS
$89.1B
$1.98M 0.01%
10,200
-379,800
-97% -$69.7M
LSCC icon
274
Lattice Semiconductor
LSCC
$18.2B
$1.98M 0.01%
+20,700
New +$1.7M
FIS icon
275
Fidelity National Information Services
FIS
$21.9B
$1.91M 0.01%
+35,200
New +$2.29M

Similar funds

Laurion Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Laurion Capital Management held 537 positions worth $14.7B, down 31% from $21.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Laurion Capital Management withdrew a net $8.87B in Q1 2023, closing 111 positions and reducing 139 holdings. Its most notable exit was Amazon, an estimated $378M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 3.4% a quarter earlier, followed by Technology and Utilities.

Against the trend, Laurion Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $72.7M.

  • Laurion Capital Management's largest Q1 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 666,036 shares worth $72.7M.
  • Laurion Capital Management added most to Altimmune in Q1 2023, an estimated $32.7M increase.
  • Laurion Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $65.9M.
  • Laurion Capital Management fully exited Amazon in Q1 2023, selling an estimated $378M.
  • Laurion Capital Management's ten largest holdings make up 31% of its $14.7B portfolio in Q1 2023.
  • Laurion Capital Management opened 135 new positions and closed 111 in Q1 2023.
  • Laurion Capital Management's portfolio value fell 31% quarter-over-quarter to $14.7B.

Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.